K

Kymeris Therapeutics Inc.

10 employees

Biotech firm with Next Generation Cellular Immunotherapy platform against solid cancer in late Discovery Phase

Basic info

Industry

biotechnology research

Sectors

Biotechnology
oncolytic
immunooncology
ovarian cancer
solid state tumor
solid state cancer
cellular
solid tumour
inoperable cancer
oncotherapy
immunotherapy
oncology
immunostimulant
pharmaceutical
eukaryote
cancer
disseminated cancer
Health Care
melanoma
carcinoma
microbial
solid tumor
metastases
biopharmaceutical
CUP
lymphoma
cancer vaccine
glioblastoma
metastasis

Date founded

2017

FAQ